SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-20-000008
Filing Date
2020-02-19
Accepted
2020-02-19 07:00:22
Documents
8
Period of Report
2020-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k021920ccoannouncem.htm 8-K 50326
2 EX-99.1 pressreleaseclavelli.htm EX-99.1 12350
3 EX-99.2 employmentagreement.htm EX-99.2 139981
4 EX-99.3 nqstockoptionagreement.htm EX-99.3 73132
5 EX-99.4 relocationagreement.htm EX-99.4 46493
6 image1.jpg GRAPHIC 7167
7 image11.jpg GRAPHIC 67437
8 optinoselogorgba051.jpg GRAPHIC 10067
  Complete submission text file 0001494650-20-000008.txt   440501
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 20627408
SIC: 2834 Pharmaceutical Preparations